Cargando…
Dual activity inhibition of threonine aspartase 1 by a single bisphosphate ligand
Therapy resistance remains a challenge for the clinics. Here, dual-active chemicals that simultaneously inhibit independent functions in disease-relevant proteins are desired though highly challenging. As a model, we here addressed the unique protease threonine aspartase 1, involved in various cance...
Autores principales: | Höing, Alexander, Struth, Robin, Beuck, Christine, Rafieiolhosseini, Neda, Hoffmann, Daniel, Stauber, Roland H., Bayer, Peter, Niemeyer, Jochen, Knauer, Shirley K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709806/ https://www.ncbi.nlm.nih.gov/pubmed/36545626 http://dx.doi.org/10.1039/d2ra06019a |
Ejemplares similares
-
Chemico-genetic strategies to inhibit the leukemic potential of threonine aspartase-1
por: Wünsch, D, et al.
Publicado: (2012) -
Computational model predicts protein binding sites of a luminescent ligand equipped with guanidiniocarbonyl-pyrrole groups
por: Rafieiolhosseini, Neda, et al.
Publicado: (2022) -
Functional Disruption of the Cancer‐Relevant Interaction between Survivin and Histone H3 with a Guanidiniocarbonyl Pyrrole Ligand
por: Vallet, Cecilia, et al.
Publicado: (2020) -
Activation of IP(3) receptors by synthetic bisphosphate ligands
por: Sureshan, Kana M., et al.
Publicado: (2009) -
NMR Spectroscopy of supramolecular chemistry on protein surfaces
por: Bayer, Peter, et al.
Publicado: (2020)